Preliminary scientific studies reveal conolidine may inhibit specific ion channels, decreasing neuronal excitability and restricting discomfort alerts. This system is especially pertinent in neuropathic ache, wherever irregular signaling triggers persistent irritation. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathway